71P The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: A Turkish Oncology Group (TOG) study
| Autor: | Yildirim, H.C., Kutlu, Y., Mutlu, E., Aykan, M.B., Korkmaz, M., Yalcin, S., Sakalar, T., Celayir, O.M., Kayikcioglu, E., Aslan, F., Hafizoglu, E., Keskinkilic, M., Celebi, A., Dursun, B., Kapar, C., Ozen, M., Acar, O., Dulgar, O., Kut, E., Aksoy, S. |
|---|---|
| Zdroj: | In ESMO Open February 2024 9 Supplement 1 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|